Hiv Patient
Hiv Patient articles
mChip can revolutionize medical care around the worldNew low-cost diagnostics like the mChip can revolutionize medical care around the world, revealed by researcher in US. Microfluidics-the manipulation of small amounts of fluids-and nanoparticles can be successfully leveraged to produce a functional low-cost diagnostic device in extreme resource-limited settings.
HIV drugs may cause premature agingResearchers revealed that a class of anti-retroviral drugs (NRTIs) commonly used to treat HIV can cause premature ageing, as the drugs damage DNA in the patient's mitochondria. HIV-infected people treated with antiretroviral drugs sometimes show advanced signs of frailty and age-associated diseases such as cardiovascular disease and dementia at an early age.
Developing possibility of a preventive vaccine against HIV AIDSThe HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization (WHO). Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.
HIV infected at higher risk for bone fracturesLow bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture, revealed by researchers.
Stroke rate rises in HIV patientsWhile the overall hospitalization rate for stroke has declined in recent years, the numbers have jumped dramatically for patients infected with human immunodeficiency virus (HIV), suggesting they may be up to three times more likely to suffer a stroke than people uninfected by the virus that causes AIDS.
Routine HIV screening in community boosts HIV testingUCSF researchers have that found routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV.
AIDS patients get benefit from early retroviral useHIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.
HIV positive have good survival rate after liver transplantHIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark.
LUCAS cell phone to monitor HIV and malaria patientsCell phones have already revolutionized the way people around the world communicate and do business. Thanks to advances being made at UCLA, they are about to do the same thing for medicine.
A man defeated HIV virus through bone marrow transplantAn HIV-positive person, who underwent a bone marrow transplant to treat leukemia, has had undetectable HIV viral loads for almost two years. HIV-positive man was ill from leukemia and had underwent treatment by the team led by Prof. Eckhard Thiel, director of the Medical Clinic with a focus on hematology and oncology.
TIM 3 protein turns off HIV fighting T cellsIn HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing capacity.
HIV infected patients should start HAART soonerUnder current treatment guidelines, highly active antiretroviral therapy (HAART) should be considered for HIV-infected patients when their CD4+ T-cell counts fall below 350 cells per cubic millimeter (mm3).
Antiretrovirals with TB treatment reduces mortality in HIV patientsA South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time.
Indian doctors can't deny HIV+, AIDS patientsIndia's Supreme Court has approved the Indian Govt.'s direction to all States that doctors in government and private hospitals should not refuse treatment to People Living with HIV/AIDS (PLHA).
Monitoring AIDS treatment by physical signs is effectiveWhen millions of HIV-infected people in poor countries began receiving advanced drug therapies, critics worried that patient care would suffer because few high-tech laboratories were available to guide treatments. But according to a study being published in The Lancet, these concerns are as yet unfounded.
CD16 monocyte could be a biomarker for progression of HIVAn increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University, reported in the March issue of AIDS Research and Human Retroviruses.
Growth hormone enhances immunity in HIV patientsGrowth hormone helps boost the immune system of HIV patients, revealed by researchers. Growth hormone (GH) treatment was associated with increased thymic mass, and increased the number of immune cells HIV patients had circulating in their blood.
273 human proteins required for HIV propagationCurrent drugs attack HIV itself, leaving patients vulnerable to counterattack by the rapidly mutating virus, which often evolves resistance. But the human proteins exploited by HIV represent potential therapeutic targets that could avoid this problem. The challenge will be to develop drugs that inhibit HIV by interacting with these human proteins without hurting our cells.
18 Hiv Patient articles listed above.